SOLICITATION NOTICE
D -- Surveillance Epidemiology and End Results (SEER) Electronic Data Capture Software Support and Installations
- Notice Date
- 6/12/2015
- Notice Type
- Presolicitation
- NAICS
- 511210
— Software Publishers
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 1050, Frederick, Maryland, 21702, United States
- ZIP Code
- 21702
- Solicitation Number
- N02PC52605-57
- Point of Contact
- Reyes Rodriguez, Phone: 240-276-5442, Seena Ninan, Phone: 240-276-5419
- E-Mail Address
-
reyes.rodriguez@nih.gov, ninans@mail.nih.gov
(reyes.rodriguez@nih.gov, ninans@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Division of Cancer Control & Population Sciences (DCCPS), is anticipating a 5-year follow on non-competitive contract to Artificial Intelligence in Medicine (AIM) in Canada in a sole source basis to procure services to continue maintaining and updating exiting SEER ePath networks. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1 (b)(2) and 13.501-(a)(1) using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System code is 511210 and the employee size standard is $38.5 Million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract/IDIQ. It has been determined there are no opportunities to acquire green products or services for this procurement. Period of Performance will be for a period of five (5) years from award date. The purpose of this acquisition is to award a 5-year follow-on contract to: 1) maintain and update the existing Surveillance Epidemiology and End Results (SEER) ePath network; 2) expand the SEER network to additional pathology laboratories; 3) expand electronic data capture to include electronic reports from diagnostic imaging, and 4) install cancer data forwarding module in previously installed ePath laboratories. This contract will consist of the EPath Application Support & Version Upgrade Fee and will set upper limits to (1) the number of hours providing operational support and configuration changes, (2) EPath installations, (3) Diagnostic Imaging installations, and (4) Cancer Data Forwarding Module installations. The Surveillance Epidemiology and End Results (SEER) Program of the National Cancer Institute is an authoritative source of information on cancer incidence and survival in the United States. Case ascertainment for SEER began on January 1, 1973, in the states of Connecticut, Iowa, New Mexico, Utah, and Hawaii and the metropolitan areas of Detroit and San Francisco-Oakland. During 1974-1975, the metropolitan area of Atlanta and the 13-county Seattle-Puget Sound area were added. In 1978, 10 predominantly black rural counties in Georgia were added, followed in 1980 by the addition of American Indians residing in Arizona. In 1992, the SEER Program was expanded to include the Alaska Native population in the State of Alaska as well as to increase coverage of the minority populations, especially Hispanics, in Los Angeles County and four counties in the San Jose-Monterey area south of San Francisco. In 2001, the SEER Program expanded its coverage to include Kentucky, the remainder of the State of California, New Jersey, and Louisiana. In 2010, the remainder of the State of Georgia also entered the program. The SEER Program currently collects and publishes cancer incidence and survival data from 20 population-based cancer registries covering approximately 28 percent of the US population. Information on more than 8.6 million in situ and invasive cancer cases is included in the SEER database, and approximately 450,000 new cases are accessioned each year within the SEER catchment areas. The SEER registries routinely collect data on patient demographics, primary tumor site, morphology, and stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage. Contractor Requirements: The Contractor shall perform the following tasks: TASK 1: Core and Administration 1) Provide renewal of all existing AIM site licenses previously purchased by the National Cancer Institute and installed within SEER Program registries. 2) Meet weekly with the NCI COR to discuss ongoing progress and resolve any issues. 3) Provide a written summary of progress to the NCI COR quarterly TASK 2: Maintenance and Installation 1) Maintain and update the existing SEER ePath network. This includes updating previously installed pathology laboratories to the latest version of AIM's TransMed 2 software, updating AIM's Autocode software, and troubleshooting and correcting laboratory reporting issues. 2) Install the ePath automated cancer identification application in laboratories within the SEER program. The laboratories shall be selected under the direction of the NCI Contracting Officer Representative (COR) and in consultation with the SEER registries from either the currently maintained list of potential laboratories or to newly identified laboratories. 3) Install diagnostic imaging modules to in radiology departments within the SEER program. The radiation departments shall be selected under the direction of the NCI Contracting Officer Representative (COR) and in consultation with the SEER registries from either the currently maintained list of potential radiology departments or to newly identified radiology departments. 4) Install cancer forwarding modules in existing ePath installations which lack this feature. The existing ePath installations will be selected by the COR. Artificial Intelligence in Medicine (AIM) is the sole-source provider of the software developed to automate the review of pathology reports cancer case finding and the forwarding of those that are required by a cancer registry. AIM is also the sole-source provider of a Cancer Data Forwarding Module which work in conjunction with previously installed AIM ePath. These products are proprietary to AIM, Inc. and are unavailable through any other distributor. Thus, AIM is the only vendor known that can meet the Government's needs at this time. This notice is not a request for competitive quotation. However, if any interested party, especially small business believes it can meet the above requirement, it may submit a proposal or quote for the Government to consider. The response and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 11 AM EST, on June 26, 2015. All responses and questions must be in writing and faxed to 240-276-5399 or emailed to Reyes Rodriguez, Contracting Specialist via electronic mail at reyes.rodriguez@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through sam.gov. Reference: N02PC52605-57 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF/N02PC52605-57/listing.html)
- Place of Performance
- Address: TBA, United States
- Record
- SN03762741-W 20150614/150612235010-d7562af00a6c1b928ac9db5c14bfb0c7 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |